Abstract |
Effects of intact and processed bovine milk proteins on development of chemically induced mammary tumors in female rats were compared. AIN-93G diets were made with 20% casein (CAS), casein hydrolysate (CASH), intact whey protein (IWP), or whey protein hydrolysate (WPH). Pregnant Sprague-Dawley rats were fed the diets starting at Gestational Day 4. Offspring were fed the same diet. At 50 days, female offspring (44-49/group) were gavaged with sesame oil containing 80 mg/kg of the mammary carcinogen dimethylbenzanthracene (DMBA) and euthanized 62 days posttreatment. Rats fed WPH had an adenocarcinoma incidence of 17% compared to the rats fed CAS, CASH, and IWP diets (34%, 33%, and 36% respectively) (P < 0.001). Median palpable tumor latency for rats fed WPH was greater (61 days, P < 0.001) compared to CAS (44 days), CASH (42 days) and IWP (45 days). Tumor multiplicity was also lower (1.5 vs. 3.0, P < 0.05) in rats fed WPH than in CAS and CASH fed groups. Results demonstrate that hydrolytic processing of whey protein is required for this diet to be effective in reducing DMBA-induced mammary tumors. The bioactive compounds produced during whey protein processing and mechanisms underlying the anticancer effects of WPH are yet to be identified.
|
Authors | Martin J Ronis, Reza Hakkak, Soheila Korourian, Thomas M Badger |
Journal | Nutrition and cancer
(Nutr Cancer)
Vol. 67
Issue 6
Pg. 949-53
( 2015)
ISSN: 1532-7914 [Electronic] United States |
PMID | 26168336
(Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Carcinogens
- Caseins
- Protective Agents
- Protein Hydrolysates
- Whey Proteins
- 9,10-Dimethyl-1,2-benzanthracene
- casein hydrolysate
|
Topics |
- 9,10-Dimethyl-1,2-benzanthracene
(toxicity)
- Animals
- Carcinogens
(toxicity)
- Caseins
(pharmacology)
- Diet
- Disease Models, Animal
- Female
- Mammary Neoplasms, Animal
(chemically induced, drug therapy)
- Pregnancy
- Protective Agents
(pharmacology)
- Protein Hydrolysates
(pharmacology)
- Rats
- Rats, Sprague-Dawley
- Whey Proteins
(pharmacology)
|